High-quality medicines to treat a range of conditions
In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.
Quick Links
Consumer Product Safety Improvement Act and CRC products
Related news
Hikma provides update on status of ANDA for generic Advair Diskus®
22 September 2020
Hikma launches Azacitidine for Injection
10 September 2020
Hikma launches Dacarbazine for Injection, USP
24 July 2020